肠道菌群
内分泌学
内科学
阿克曼西亚
骨骼肌
毛螺菌科
失调
生物
高脂血症
肠道通透性
移植
炎症
下调和上调
胃肠道
代谢综合征
肌肉萎缩
医学
肌萎缩性肥胖
脂肪组织
肥胖
肠-脑轴
免疫学
植物甾醇
脂质代谢
胆固醇
化学
全身炎症
作者
Zhiyuan Feng,Jiayue Xia,Zhenzhen Zhang,W. J. YAN,Yanyan Tian,Tianyu Wu,Yingqi Shao,Zhenyang Zhang,Zhiwen Zhang,Yuchao Han,Ming Huang,Shaokang Wang,Hui Xia,Wang Liao,Guiju Sun
标识
DOI:10.1016/j.jfutfo.2025.12.042
摘要
ABSTRACT Objective Sarcopenic obesity (SO) is prevalent and linked to intramuscular fat accumulation under hyperlipidemia. Phytosterols (PS) can reduce hyperlipidemia by inhibiting intestinal cholesterol absorption and modulating gut microbiota. In this study, we employed a high-fat diet (HFD) rat model to investigate the therapeutic potential of dietary PS supplementation against SO. Methods HFD-induced SO rats received oral PS for 12 weeks. We assessed body weight, grip strength, serum inflammatory markers, and intestinal barrier indicators. Gut microbiota was profiled by 16S rRNA sequencing, and skeletal muscle proteins were analyzed by Western blot. Fecal microbiota transplantation (FMT) tested microbiota causality. Results PS treatment resulted in a 1.48-fold increase in relative grip strength and a 1.18-fold increase in the median muscle fiber cross-sectional area compared with the HFD group. PS treatment significantly attenuated systemic chronic inflammation, reducing circulating pro-inflammatory cytokines-TNF-α by 33.21%, IL-1β by 43.66%, and IL-6 by 43.54%-compared with the HFD group (all P <0.05). PS significantly altered gut microbiota composition, resulting in a 2.06-fold enrichment of Allobaculum and a 28.15-fold enrichment of Akkermansia (both P < 0.05). Concurrently, it enhanced intestinal barrier integrity and lowered serum diamine oxidase, D-lactate, and endotoxin concentrations (all P < 0.05). PS suppressed IkappaB kinase beta (IKBKB)-NF-kappa B (NF-κB) signaling in skeletal muscle, upregulated dynamin-related protein 1 (DRP1) expression, and downregulated Forkhead Box O3A (FOXO3A) expression (all P < 0.05), thereby enhancing mitochondrial function and ameliorating muscle atrophy. FMT experiments confirmed the critical role of gut microbiota in mediating PS protective effects. Conclusion PS exerts its preventive effects against high-fat diet-induced sarcopenic obesity by reshaping gut microbiota structure, improving intestinal barrier function, alleviating systemic chronic inflammatory responses, and regulating IKBKB-NF-κB signaling pathway and DRP1/FOXO3A protein expression. These findings highlight the potential of PS as a therapeutic approach to prevent SO.
科研通智能强力驱动
Strongly Powered by AbleSci AI